Showing results (191-200 of 201) with videos related to
Sort By:
Pageof 21
Respiratory Medicine|September 14, 2013
Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosisKyung-Wook Jo, Yoonki Hong, Young Ju Jung, et al.Arthritis & Rheumatology (Hoboken, N.J.)|November 26, 2019
Negative Regulation of Osteoclast Commitment by Intracellular Protein Phosphatase Magnesium-Dependent 1AOh Chan Kwon, Bongkun Choi, Eun-Jin Lee, et al.Gut and Liver|May 27, 2016
Endoscopic Findings of Upper Gastrointestinal Involvement in Primary VasculitisEun Jeong Gong, Do Hoon Kim, Joo Hyun Chun, et al.Cellular and Molecular Life Sciences : CMLS|June 10, 2010
Interleukin-33 stimulates formation of functional osteoclasts from human CD14(+) monocytesSe Hwan Mun, Na Young Ko, Hyuk Soon Kim, et al.Atherosclerosis|July 29, 2019
Serum uric acid level and subclinical coronary atherosclerosis in asymptomatic individuals: An observational cohort studyDoo-Ho Lim, Yongjik Lee, Gyung-Min Park, et al.Immune Network|January 17, 2022
SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction ResiduesSinae Kim, Tam T Nguyen, Afeisha S Taitt, et al.Journal of Clinical Medicine|December 10, 2020
Autoantibodies against Protein Phosphatase Magnesium-Dependent 1A as a Biomarker for Predicting Radiographic Progression in Ankylosing Spondylitis Treated with Anti-Tumor Necrosis Factor AgentsJung-Sun Lee, Eun-Ju Lee, Jae-Hyun Lee, et al.The Korean Journal of Internal Medicine|November 22, 2005
Double autologous stem cell transplantation for multiple myeloma: a Korean single center studyOck Bae Ko, Shin Kim, Hyeok Shim, et al.Plos One|April 22, 2016
Safety of Resuming Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis Patients Concomitant with the Treatment of Active Tuberculosis: A Retrospective Nationwide Registry of the Korean Society of Spondyloarthritis ResearchHye Won Kim, Seong Ryul Kwon, Kyong-Hee Jung, et al.Seminars in Arthritis and Rheumatism|April 17, 2025
Real-world comparative effectiveness study of Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs in Korean patients with rheumatoid arthritisSoo-Kyung Cho, Se Rim Choi, Hye Won Kim, et al.Pageof 21